CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 68 enrolled
Drug / intervention
Glargine and regular insulin versus NPH and regular insulindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05709938
NCT05709938Phase 4Completed

Comparison of Insulin Glargine Mixed With Regular Insulin Versus the Standard Neutral Protamine Hagedorn (NPH) and Regular Insulin in the Treatment of Type 1 Diabetes Mellitus

King Edward Medical University·interventional·Posted Feb 2, 2023·Updated Feb 2, 2023

In Brief

A Phase 4 clinical trial evaluating Glargine and regular insulin versus NPH and regular insulin for To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children. Completed, enrolled 68 participants across 1 site.

Detailed Summary

To compare the glycemic control in children with type 1 diabetes using insulin Glargine and regular insulin as basal bolus therapy versus Neutral Protamine Hagedorn insulin (NPH) and regular insulin.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesPakistan
Collaborators--

Timeline

Phase 4CompletedFinished
2020202120222023202420252026
First PostedFeb 2, 2023
Enrollment StartNov 1, 2019
Primary CompletionJan 5, 2021
Study CompletionApr 20, 2021
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 3.4 years ago

Interventions

Glargine and regular insulin versus NPH and regular insulindrug

Patients with type 1 diabetes (T1DM) in group A received insulin glargine as basal therapy at night and regular insulin given prior to each main meal. Patients in group B were given NPH and regular insulin in split and mix method in the morning and evening.